Treatment News : Liver Transplants Are a Viable Option for People With HIV

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » May 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

May 20, 2013

Liver Transplants Are a Viable Option for People With HIV

People with HIV who undergo liver transplants for hepatocellular carcinoma (HCC), the most common form of liver cancer, appear to fare as well as those without the virus, WebMD reports. Publishing their findings in The Oncologist, Italian researchers conducted the largest multicenter study of liver transplant for HCC in HIV-positive people to date. The study evaluated the outcomes of 30 HIV-positive participants and 125 HIV-negative participants after they received liver transplants for HCC between 2004 and 2009.

Two of those with HIV (6.7 percent) and 18 of those in the uninfected group (14.4 percent) saw their HCC recur during a follow-up period of just less than three years. Survival rates were comparable between the two groups: One year after transplantation, 77 percent of the HIV-positive participants were living, compared with 86.4 percent for the HIV-negative participants; after three years, the rates were a respective 65 and 70 percent.

“The key message of this study is that liver transplantation is a valid option for HCC treatment in HIV-infected patients,” the study authors write. “We suggest that HIV-infected patients must be offered the same liver transplant options for HCC treatment currently provided to HIV-uninfected subjects.”

The study is limited by its small sample size, resulting in lower statistical significance to the data, meaning there is a greater possibility that chance may have played a role in the findings.

To read the WebMD story, click here.

To read the study release, click here.

To read the study abstract, click here.

Search: hepatocellular carcinoma, HCC, HIV, liver transplant, The Oncologist, WebMD.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    fokisi
    Long Beach
    California


    romanticseattle
    Tacoma
    Washington


    max38man
    Chicago
    Illinois

This could be you!
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.